The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project : A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors
Copyright © 2023 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved..
INTRODUCTION: A lymph node map is the pillar on which accurate assignment and documentation of nodal classification stands. The International Thymic Malignancy Interest Group created the first map for thymic epithelial malignancies in conjunction with the eighth edition of the TNM classification, representing the first official TNM classification of thymic epithelial malignancies. The map was based on clinical experience and published studies, but it was largely empirical because of limited available data. Dissemination of the map and implementation of a standard thymic stage classification across the world in 2017 have provided more consistent and granular data.
METHODS: More than twice as many cases of node involvement are available for analysis in the current database compared with that of the eighth edition database, allowing validation of many aspects of the eighth edition map. This article details the process and considerations for refinement of the thymic map for the ninth TNM used by the Thymic Domain of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer. The committee evaluated a large international collaborative data set, published anatomical and clinical studies pertaining to lymph node spread from thymic epithelial tumors, in conjunction with the analysis underlying refinements of the TNM components for the ninth edition TNM classification.
RESULTS: The node map boundaries of the N1 and N2 categories remain unchanged. Visual clarifications have been added to the nomenclature of nodal stations within these regions.
CONCLUSIONS: On the basis of the recommendation to keep the N component unchanged for the ninth edition TNM classification, the lymph node map remains unchanged as well; however, clarifications have been added to facilitate clinical use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 18(2023), 12 vom: 09. Dez., Seite 1672-1688 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 24.11.2023 Date Revised 27.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jtho.2023.09.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361868758 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361868758 | ||
| 003 | DE-627 | ||
| 005 | 20231229123854.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jtho.2023.09.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1240.xml |
| 035 | |a (DE-627)NLM361868758 | ||
| 035 | |a (NLM)37689390 | ||
| 035 | |a (PII)S1556-0864(23)00803-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Marom, Edith M |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project |b A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.11.2023 | ||
| 500 | |a Date Revised 27.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a INTRODUCTION: A lymph node map is the pillar on which accurate assignment and documentation of nodal classification stands. The International Thymic Malignancy Interest Group created the first map for thymic epithelial malignancies in conjunction with the eighth edition of the TNM classification, representing the first official TNM classification of thymic epithelial malignancies. The map was based on clinical experience and published studies, but it was largely empirical because of limited available data. Dissemination of the map and implementation of a standard thymic stage classification across the world in 2017 have provided more consistent and granular data | ||
| 520 | |a METHODS: More than twice as many cases of node involvement are available for analysis in the current database compared with that of the eighth edition database, allowing validation of many aspects of the eighth edition map. This article details the process and considerations for refinement of the thymic map for the ninth TNM used by the Thymic Domain of the Staging and Prognostic Factors Committee of the International Association for the Study of Lung Cancer. The committee evaluated a large international collaborative data set, published anatomical and clinical studies pertaining to lymph node spread from thymic epithelial tumors, in conjunction with the analysis underlying refinements of the TNM components for the ninth edition TNM classification | ||
| 520 | |a RESULTS: The node map boundaries of the N1 and N2 categories remain unchanged. Visual clarifications have been added to the nomenclature of nodal stations within these regions | ||
| 520 | |a CONCLUSIONS: On the basis of the recommendation to keep the N component unchanged for the ninth edition TNM classification, the lymph node map remains unchanged as well; however, clarifications have been added to facilitate clinical use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Thymic carcinoma | |
| 650 | 4 | |a Thymic malignancy | |
| 650 | 4 | |a Thymic neuroendocrine tumor | |
| 650 | 4 | |a Thymic node map | |
| 650 | 4 | |a Thymoma | |
| 700 | 1 | |a Fang, Wentao |e verfasserin |4 aut | |
| 700 | 1 | |a Ruffini, Enrico |e verfasserin |4 aut | |
| 700 | 1 | |a Detterbeck, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Usman |e verfasserin |4 aut | |
| 700 | 1 | |a Appel, Sarit |e verfasserin |4 aut | |
| 700 | 1 | |a Bille, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Boubia, Souheil |e verfasserin |4 aut | |
| 700 | 1 | |a Brambilla, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Cilento, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Cangir, Ayten Kayi |e verfasserin |4 aut | |
| 700 | 1 | |a Falkson, Conrad |e verfasserin |4 aut | |
| 700 | 1 | |a Filosso, Pier Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Giaccone, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Girard, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Goren, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Guerrera, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, James |e verfasserin |4 aut | |
| 700 | 1 | |a Infante, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Dong-Kwan |e verfasserin |4 aut | |
| 700 | 1 | |a Lucchi, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Marino, Mirella |e verfasserin |4 aut | |
| 700 | 1 | |a Nicholson, Andrew G |e verfasserin |4 aut | |
| 700 | 1 | |a Okumura, Meinoshin |e verfasserin |4 aut | |
| 700 | 1 | |a Rami-Porta, Ramon |e verfasserin |4 aut | |
| 700 | 1 | |a Rimner, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Simone, Charles B |c 2nd |e verfasserin |4 aut | |
| 700 | 1 | |a Asamura, Hisao |e verfasserin |4 aut | |
| 700 | 0 | |a Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards and Participating Institutions |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |d 2006 |g 18(2023), 12 vom: 09. Dez., Seite 1672-1688 |w (DE-627)NLM169435504 |x 1556-1380 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:12 |g day:09 |g month:12 |g pages:1672-1688 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jtho.2023.09.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 12 |b 09 |c 12 |h 1672-1688 | ||